. . . . . . . . . . . . "a(CHEBI:rosiglitazone) -> p(MGI:Irs1)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "Additionally, rosiglitazone increased IRS-1 and IRS-2 levels, thereby enhancing insulin effects on IRS-1- and IRS-2-dependent PI3K and downstream signaling factors PKC-lambda and protein kinase B" . . "Selventa" . . . . "2014-07-03T14:31:48.431+02:00"^^ . . .